11:30 am – 12:00 pm PDT Featured Featured When It Could Be Cystic Fibrosis (CF): Diagnosing CF in People with Atypical Disease Presentation
11:30 am – 12:30 pm PDT Featured Featured Clinical and patient-centered discussions on the role of inflammation in bronchiectasis
11:55 am – 12:15 pm PDT Advances in Ventilation and Perfusion (VQ) Assessment in COPD, CTEPH and Other Chronic Pulmonary Vascular Disorders
12:00 pm – 12:30 pm PDT Should We Be Targeting Eosinophils Regardless of Allergic Status in Patients With Severe Eosinophilic Asthma?
12:15 pm – 12:35 pm PDT Featured Featured Elevating Asthma Control: Implications for Your Pediatric Patients
12:30 pm – 1:00 pm PDT Implementing Treprostinil Induction Strategies in Pulmonary Arterial Hypertension
1:00 pm – 1:30 pm PDT A Brief Review of Clinical Insights for Identifying and Managing Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA)
1:15 pm – 1:35 pm PDT Clearing the air: Navigating the diagnosis and management of Bronchiolitis obliterans syndrome (BOS) after lung transplant
1:15 pm – 2:00 pm PDT Featured Featured Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management
1:30 pm – 2:15 pm PDT Disease Characteristics, Treatments, and Outcomes: Recent Findings From a Large, Real-World, PAH Drug Registry
1:35 pm – 1:55 pm PDT The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on inflammation
6:30 pm – 8:00 pm PDT Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understanding Disease Burden, Diagnosing Early, and Looking Toward New Management Options
6:30 pm – 9:00 pm PDT Asymmetrical Nasal High Flow: A New Paradigm in Noninvasive Respiratory Support
6:30 pm – 9:30 pm PDT Epithelial Cytokines: Connecting the Dots in Severe Asthma, Nasal Polyps, and COPD
6:30 pm – 9:30 pm PDT Approaches to COPD care: Targeting the ST2 receptor and IL-33 pathway as a potential option for patients at risk of exacerbating
11:30 am – 12:00 pm PDT Featured Featured Asthma Drivers of Disease: the effects of IL-5 on eosinophils and other cell types that contribute to airway remodeling and disease progression.
11:30 am – 12:15 pm PDT New Insights Into Triple Therapy for COPD: A Focus on the Latest Real-World Evidence
11:30 am – 12:30 pm PDT Featured Featured Interstitial Lung Disease: Presentation to Patient Experience
11:35 am – 11:55 am PDT Treating hyperinflammation as an unmet need in CAP: Investigational agent reparixin and the REPAVID-22 trial
11:35 am – 11:55 am PDT Bronchoscopic Lung Volume Reduction: High Volume Community Hospital Perspective with Jason Stienecker, DO
11:55 am – 12:15 pm PDT Featured Featured Earlier Assessment of Uncontrolled Moderate-to-Severe Asthma. Is There More We Can Do?
11:55 am – 12:15 pm PDT The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on bronchoconstriction
12:00 pm – 12:30 pm PDT Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium
1:00 pm – 1:30 pm PDT Breathing Innovation: Inhaled Pirfenidone for the Treatment of Progressive Pulmonary Fibrosis
1:00 pm – 1:45 pm PDT Featured Featured Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation – Is it the Time for Precision Medicine in COPD?
1:00 pm – 2:00 pm PDT Featured Featured Clinical Considerations for Sleep Specialists on the Improvement of Wakefulness in Patients With Excessive Daytime Sleepiness
1:15 pm – 1:35 pm PDT The Healthcare of Today, Looking towards Tomorrow: Digital Innovations and Patient-Centricity
1:15 pm – 2:00 pm PDT COPD and Asthma with Type 2 Inflammation: Distinct Diseases with a Shared Cause
6:30 pm – 7:30 pm PDT Featured Featured Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
6:30 pm – 9:30 pm PDT Applying Newer Diagnostic and Therapeutic Tools to the Management of the Individual with Nontuberculous Mycobacterial Lung Disease
6:30 pm – 9:30 pm PDT An Expert Panel on Severe Asthma: From the Epithelium to Better Patient Outcomes